Beclometasone dry-powder inhalation - GlaxoSmithKline

Drug Profile

Beclometasone dry-powder inhalation - GlaxoSmithKline

Alternative Names: Beclometasone Accuhaler; Beclometasone Diskus; Beclomethasone Accuhaler; Beclomethasone Diskus; Beclomethasone dry-powder inhalation - GlaxoSmithKline; Beclovent Rotacaps; Becodisks Diskhaler; Becotide Diskus; Becotide Rotacaps

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Asthma

Most Recent Events

  • 01 Feb 2012 Withdrawn for Asthma in United Kingdom (Becodisks Diskhaler, Inhalation)
  • 31 Oct 2003 Withdrawn for Asthma in United Kingdom (Becotide Rotacaps, Inhalation)
  • 23 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top